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Background: Severe chronic venous disease frequently has a complex pathophysiology. This study describes results after
combined interventions to correct outflow obstruction and superficial reflux, even in the presence of deep venous reflux.
Methods: Between 1997 and 2005, 99 limbs in 96 patients had percutaneous iliofemoral venous stenting combined with
great saphenous vein (GSV) stripping (39 limbs), or percutaneous GSV ablation performed by radiofrequency (27 limbs)
or laser (33 limbs). Clinical severity score in CEAP was C4 in 51 limbs, C5 in eight limbs, and C6 in 40 limbs; median
age was 56 years (range, 27 to 87 years); left–right limb ratio, 2.3:1; female–male ratio, 1.8:1; primary–secondary
etiology, 58:41. Perioperative investigations included visual analogue pain scale (VAS), degree of swelling (grade 0 to 3);
quality-of-life questionnaire; venous filling index in milliliters per second (VFI90), venous filling time in seconds (VFT),
percentage in ambulatory venous pressure drop (AVP), duplex Doppler scanning, and radiologic studies.
Results: Clinical follow-up was performed in 97 (98%) of 99 for up to 5.5 years. Axial deep reflux was found in 27%
(27/99). At least three venous segments were refluxing in 40% of limbs. Preoperative hemodynamic parameters reflected
the presence of reflux and improved significantly (P < .01) after the procedure (VFI90, 3.8 to 2.3 mL/s; VFT, 11 to 16
seconds; AVP, 55% to 65%). No patients died, and the morbidity with endovenous GSV ablation was largely limited to
ecchymosis and thrombophlebitis in the thigh area. Cumulative primary, assisted primary, and secondary stent patency
rates at 4 years were 83%, 97%, and 97%, respectively. After treatment, limb swelling and pain substantially improved. The
rate of limbs with severe pain (>5 on VAS) fell from 44% to 3% after intervention. Gross swelling (grade 3) decreased
from 30% to 6% of limbs. Cumulative analysis showed sustained complete relief of pain (VAS  0) and swelling (grade 0)
after 4 years in 73% and 47% of limbs, respectively. Ulcers healed in 26 (68%) of 38 ulcerated limbs. Cumulative
ulcer-healing rate was 64% at 48 months. All quality-of-life categories significantly improved after treatment.
Conclusion: The single-stage combination of percutaneous venous stenting and superficial ablation in patients with severe
chronic venous disease is safe, gives excellent symptom relief and improvement of quality of life, and a well-maintained
ulcer-healing rate. It seems logical to initially perform multiple minimally invasive interventions rather than open surgery.
Any associated deep reflux can initially be ignored pending clinical response to the combined intervention. (J Vasc Surg
2006;44:828-33.)The evolution in surgery as a whole is towards less
invasive procedures. This is true for general surgery and
various subspecialties. Open removal of the gall bladder has
been replaced by laparoscopic cholecystectomy, and ab-
dominal aortic aneurysm is often controlled by aortic stent
grafts. The approach towards treatment for chronic venous
disorders has also changed with the introduction of mini-
mally invasive techniques. Saphenous vein stripping has
largely been replaced by endovenous obliteration tech-
niques.1,2 The safe and efficient percutaneous stenting of
femoral-ilial-caval outflow obstruction has largely replaced
open bypass surgery.
It has also focused interest on the importance of
outflow obstruction in the projection of symptoms and
allowed relatively simple treatment with wider applicabil-
ity.3,4 When complex venous disease is present with severe
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828clinical symptoms, often multiple venous segments are
involved by obstruction or reflux. This study assessed one-
stage treatment with saphenous ablation and iliofemoral
stenting for severe chronic venous disorders.
METHODS
The study patients were selected from a database of
970 consecutive patients undergoing venous stenting be-
tween October 1997 and March 2005. The CEAP classifi-
cation according to the reporting standards of Interna-
tional Society of Cardiovascular Surgeons (ISCVS)/Society
of Vascular Surgeons (SVS) had been used to assess prest-
enting clinical severity.5,6 The selected limbs belonged to
the clinical severity class 4 to 6 in the CEAP classification,
had a combination of great saphenous vein (GSV) reflux
(with or without deep reflux) and iliofemoral obstruction,
and had no previous interventions for the venous disease.
These criteria were used to identify 99 limbs in 96 patients,
which were included in the analysis.
The obstructive lesion was considered thrombotic
when the patient had a known history of deep venous
thrombosis (DVT) or when postthrombotic changes in the
lower extremity were found on venogram or duplex ultra-
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before treatment.
Duplex Doppler study. Standardized compression-
release was used for this study.7 Duration of reflux 0.5
seconds was considered significant. The pattern of reflux
was reported in two ways: (1) in a deep axial fashion,
mimicking Kistner’s classification, giving 1 to 4 points, as
the reflux involved common femoral, femoral, popliteal,
and distal posterior tibial veins, consecutively; (2) in a
multisegment score with 1 point each awarded to the
femoral, profunda, popliteal, posterior tibial, above and
below knee great saphenous, and small saphenous veins
(maximum score  7), whether or not axial reflux was
present.8-10 Deep reflux reaching below the popliteal vein
(ie, Kistner classes 3 and 4) was considered axial and severe.
Duplex ultrasound imaging was also used to assess patency
of pelvic stents postinsertion.
Ambulatory venous pressure measurement. The
pressure was recorded in the dorsal vein with the patient
standing erect and motionless and holding on to a frame,
during ten toe-stands, and throughout the period of pres-
sure recovery to baseline level. The ambulatory venous
pressure was measured as percent drop of baseline pressure
at rest to the level at the end of the exercise (AVP, %). The
time required for the pressure to return to base level was the
venous filling time (VFT, seconds).
Air plethysmography. Details of air plethysmography
using APG-1000 (ACIMedical Inc, Sun Valley, Calif ) have
been described by Christopolous et al.11 Venous filling
index (VFI, mL/s), measured at 90% of total increase of calf
volume when shifting from the supine to the erect position
(VFI90), has been shown to be a useful parameter to reflect
global venous hemodynamics.8
Ascending and transfemoral venography. Injection
of contrast medium into the common femoral or femoral
vein was made to delineate the distribution and nature of
femoral-ilial-caval morphologic changes, including occlu-
sion, stenosis, and presence of collateral circulation, and to
assess patency of inserted iliofemoral stents. Ascending
venogram with injection of contrast medium into a dorsal
foot vein was occasionally used to evaluate stent patency.
Intervention. Percutaneous stenting of the iliofemo-
ral venous outflow was performed in all patients in combi-
nation with control of the superficial reflux. Procedures
were performed in a dedicated angiography suite under
general anesthesia because patients often experience inten-
sive back pain uncontrolled by sedation and local anesthesia
during balloon angioplasty of a tight iliac vein obstruction,
the recanalization procedure may be lengthy, and multiple
phlebectomies and sharp debridement of ulcers are often
performed in the same sitting. Remaining deep reflux, if
present, was left untreated.
During 1997 to 2000, stripping of the GSV was mainly
performed, radiofrequency obliteration of the GSV was
used in 2001 and 2002, and from 2003, the GSV was
ablated by laser (810 nm). Standard techniques were used
and are described elsewhere.1,2Significant superficial saphenous vein reflux, if present,
was treated with stripping, and stab miniphlebectomies of
nontruncal varicosities were performed as indicated. The
procedure started with treatment of the superficial reflux
and a temporary compression bandage was applied up to
the lower thigh.
After femoral vein cannulation, transfemoral venogram,
and intravascular ultrasound (IVUS) imaging, but before
balloon venoplasty and stenting, 3000 units of heparin was
given intravenously. The patients also received 2500 units
of dalteparin subcutaneously before and after surgery, and
an additional dose of 5000 units was administered the
postoperative morning before discharge. Patients with
nonthrombotic disease continued taking 81 mg of aspirin
daily. Patients with thrombotic disease taking warfarin pre-
intervention continued anticoagulation postintervention
or anticoagulation with warfarin was started postinterven-
tion in patients when thrombophilia was diagnosed before
stent insertion.
The technical details of percutaneous stenting of the
iliofemoral venous outflow tract have been outlined previ-
ously.12-14 The indication for stenting was the finding of
a 50% morphologic stenosis on transfemoral venography
or IVUS imaging. Crosscut area of the stenosis was mea-
sured by IVUS and compared with the area of the normal
vein below the stenosis.
Follow-up. The treated limbs were monitored clini-
cally. The study end point of legs with stasis ulceration was
healing (ie, complete epithelialization). Most patients had
exhausted conservative treatment, including ulcer dressings,
compression stockings, and Unna boot application before
intervention, without healing of the ulcer. Compression
and local ulcer therapy was continued after intervention
until healing. Prolonged use of compression regimen in
general was not encouraged, because many considered it a
quality-of-life issue. Noncompliant patients were not fitted
with new stockings.
After intervention, the local ulcer care and compression
therapy was continued. Cumulative ulcer healing rate was
calculated including legs with ulcers that never healed and
legs with ulcers that healed but later recurred. Ulcers that
never healed were initially considered healed for up to 3
months (given time to heal) before being considered
nonhealed in the cumulative analysis. Any breakdown of
an ulcer after healing was considered a recurrence.
The degree of pain was evaluated perioperatively by
using a visual analog scale from 0 to 10, wherein 10 is the
most severe pain.15 Swelling was assessed as grade 0 (ab-
sent), grade 1 (pitting, not obvious), grade 2 (visible ankle
edema), and grade 3 (massive, encompassing the entire leg)
as per reporting standards. Patients were asked to fill out a
quality-of-life questionnaire assessing subjective pain, sleep
disturbance, morale, and social activities, as well as routine
and strenuous physical activities (CIVIQ), prospectively
before intervention and again at each subsequent postop-
erative visit.16 This quality-of-life questionnaire has been
validated for assessment of chronic venous insufficiency.
Numerical grades (1 to 5) were provided for each question,
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swers. The last available response was used in postoperative
outcome analysis.
Venous function studies were repeated on follow-up.
In addition, a single-plane transfemoral venogram, an as-
cending venogram, or an iliofemoral duplex ultrasound
scan was obtained early (2 to 3 months) after stenting,
repeated 9 months later, and then performed annually
thereafter as a routine surveillance of stent patency. If the
patient returned with recurrence of symptoms, transfemo-
ral venogram was always used to assess patency of the
venous outflow tract. In-stent restenosis, if present, was
assessed as percentage diameter reduction of patent lumen
of the stent on venogram.
Clinical data were entered prospectively into a time-
stamped electronic medical records program for subse-
quent analysis. The nonparametric Wilcoxon rank test for
paired and unpaired data and 2 were used for statistical
analysis as appropriate. The commercially available statisti-
cal program Graph Pad Prism 3 (GraphPad Software, San
Diego, Calif ) for Windows (Microsoft Corp., Redmond,
Wash) was used for analysis. Primary, assisted primary (pa-
tency after preemptive intervention), and secondary patency
(patency after intervention for occlusion) rates as defined
by the reporting standards of the SVS/ISCVS5 were calcu-
lated using survival analysis with the Kaplan-Meier method.
Cumulative survival curves were also used to analyze and
compare recurrence of pain, swelling, and ulcer after the
treatment. P  .05 was considered significant.
RESULTS
The median age of the patients was 56 years (range, 27
to 87 years). Female gender and left lower limb involve-
ment was twice as common than male gender and right
lower limb (female–male ratio was 2.3:1 and left–right
lower limb ratio was 1.8:1). The C score in CEAP was C4
(hyperpigmentation, dermatitis, lipodermatosclerosis) in
51 limbs, C5 (healed venous ulcer) in eight limbs, and C6
(active ulcer) in 40 limbs. The etiology was primary in 58
and secondary in 41 lower limbs.
The pathophysiology of all limbs included the combi-
nation of outflow obstruction and reflux. All limbs had
superficial incompetence, including GSV reflux from groin
to below the knee. In addition, deep venous reflux was
observed in 34 limbs, but axial deep reflux to below the
knee (Kistner class 3 and 4) was found in only 27 limbs
Venous hemodynamic parameters before compared with a
AVP, % drop
Pretreatment 55 (11-100) (n  83)
Post-treatment 65 (22-89)*** (n  32)
AVP, Ambulatory venous pressure; VFT, venous filling time; VFI90, venous
Data are median (range).
** .01
** .001(27%). The median multisegment score was 2 (range, 1 to 7);that is, 40% of limbs had3 segments with reflux. Preopera-
tive venous hemodynamic parameters are summarized in the
Table.
All patients underwent endovenous stenting. IVUS
detected a mean  SD area stenosis of 73%  18%. The
prestent crosscut area of the most severe stenosis was
0.47  0.30 cm2 and increased after stenting to 1.74 
0.39 cm2. Five limbs required recanalization of occlusion
before stenting. In the same sitting, the superficial reflux
was treated in all patients. Stripping of the GSV was per-
formed in 39 limbs combined with superficial saphenous
vein (SSV) stripping/stab avulsions in five, SSV stripping in
one, and stab avulsions in 18. Radiofrequency ablation of
the GSV was performed in 27 limbs combined with SSV
stripping/stab avulsion in one, and stab avulsions in six.
Endovenous laser obliteration was performed in 33 limbs
combined with SSV stripping/stabs in two, and stab avul-
sions in 18. The interventions were performed with 23
hours hospital stay.
The interventions were performed with no mortality
(30 days), and no access related complications occurred
in this series. Possibly because of severe thrombophilia, one
patient developed immediate intraoperative clotting of
the inserted stent, despite anticoagulation, and had open
thrombectomy, which failed. The stent remained closed.
Complications related to the procedure occurred in 18
patients 30 days postoperatively. The rate and severity
was lower when endovenous GSV ablation was used com-
pared with the stripping procedure.
Conservatively treated thigh thrombophlebitis, bruising,
or pulling pain, or a combination, were observed in seven
limbs and mild first-degree skin burn in one limb with radio-
frequency closure (8/60, 13%). GSV stripping resulted in
complications in nine (23%) of 39 patients: infected groin
wound surgically drained in two, conservatively treated
“strip channel” hematoma in four, and one patient each
with groin seroma, wound necrosis, and delayed wound
healing. DVT developed postoperatively in two patients.
In one patient, early DVT of the contralateral iliofemoral
vein occurred 27 days postintervention, which was suc-
cessfully lysed. Ipsilateral DVT developed in another
patient 13 months after surgery; clot removal failed.
Venography or iliofemoral venous ultrasonography was
performed one or several times in 74 limbs (75%) to verify
patency 3 to 66 months (mean, 22 months) after stent
placement. Cumulative primary, assisted primary, and sec-
reatment
VFT (seconds) VFI90, (mL/s)
1 (1-108) (n  81) 3.8 (0.4-13.2) (n  93)
6 (2-120)** (n  33) 2.3 (0.6-13.2)*** (n  62)
index measured at 90% of total increase of calf volume.fter t
1
1
fillingondary patency rates at 4 years were 83%, 97%, and 97%,
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performed during the observation period: additional stent-
ing of stenosis above and below the previous stent in one
and three limbs, respectively; balloon angioplasty of in-
stent restenosis in three limbs, and combination of these
procedures in one limb. Duplex Doppler ultrasound imag-
ing was performed in 41 of 60 limbs with endovenous GSV
obliteration (laser obliteration in 21 limbs and radiofre-
quency closure in 20 limbs). The GSV was found patent
and refluxive in 9% and 25% in limbs treated with laser and
radiofrequency, respectively.
Mean postinterventional clinical follow-up was 22
months (range, 2 to 68) and was available in 97 (98%) of 99
limbs. Before treatment, 22% of limbs were completely
pain-free and 15% had no swelling. After treatment there
was a substantial improvement of limbs with swelling and
pain. The rate of limbs with severe pain (5 on visual
analogue scale) fell from 44% to 3% after intervention.
Gross swelling (grade 3) decreased from 30% to 6% of
limbs. Cumulative outcome of pain and swelling long-term
are shown in Fig 2. These graphs are based on complete
relief (grade 0 swelling and 0 level of pain) as they provide
clear clinical endpoints. After 4 years, 73% remained com-
pletely free of pain and 47% from swelling.
The outcome of the venous ulcer was monitored n 38
of 40 ulcerated limbs. The ulcer did not heal in 12 limbs. In
the remaining 26 limbs, the ulcer healed and recurred in
only one limb during the follow-up period. Thus, ulcer
recurrence was rare if healing of the ulcer was achieved after
this intervention. The cumulative ulcer-healing rate at 4
years was 64% (Fig 3).
The quality-of-life questionnaire was introduced later
in the study explaining the shorter mean follow-up and the
smaller number of patients. Preintervention and postinter-
vention quality-of-life results were obtained in 44 patients
at mean 6months (range, 1 to 38months) after the interven-
tion. All quality-of-life categories after treatment signifi-
Fig 1. Cumulative primary, assisted primary, and secondary pa-
tency rates of iliofemoral stents. The lower numbers represent
limbs at risk for each time interval (all SEM 10%).cantly improved, including lower limb pain (P  .0016),work-related leg problems (P .0006), sleep (P .0036),
social activities (P  .0001), and morale (P  .0009).
Generally, the quality-of-life sum of scores decreased by
20% to 30%.
The venous hemodynamic parameters are given in the
Table. Air plethysmography was performed one or several
times in 63 limbs at a mean 18 months (range, 3 to 60
months) after surgery. Ambulatory venous pressure drop,
venous filling time, and venous filling index are mainly
indicators that reflux improved significantly overall. After
surgery, 16 of 27 limbs with axial deep reflux had repeat
ultrasound imaging. The deep reflux remained in all limbs
and was not affected by the correction of the superficial
reflux.
Certain characteristics of the subgroups of patients with
Fig 2. Sustained relief of pain and swelling relief after the com-
bined intervention. The cumulative curves represent limbs with
complete relief of pain and swelling, respectively. Only limbs that
had preoperative pain or swelling are shown. The lower numbers
represent limbs at risk for each time interval (all SEM 10%).
Fig 3. Cumulative rate of healed ulcer after the combined
intervention. Ulcers were given a 3-month grace period after
intervention to heal and were then considered a recurrence. The
lower numbers represent limbs at risk for each time interval (all
SEM 10%).healed ulcers (26) were compared with those with unhealed
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venous segments (3) were involved in the unhealed com-
pared with the healed group (75% and 31%, 67% and 31%,
respectively). The VFI90 remained elevated after interven-
tion in the unhealed group (6.7 mL/s) and dropped sig-
nificantly in the healed group (median 4.5 to 2.9 mL/s,
P .0004). The healing rate was 77% in the patients that
had GSV pin stripping performed compared with 62% in
the group with GSV endovenous treatment, but this was
not statistically significant (P  .318).
The clinical outcome of the 27 patients with untreated
axial deep reflux was assessed. Despite this remaining deep
reflux, there was substantial clinical improvement after the
combined intervention: 8 (50%) of 16 ulcerated limbs
healed, 6 (27%) of 22 swollen legs were completely free of
swelling, and 13 (68%) 19 patients with pain were com-
pletely pain-free.
DISCUSSION
The treatment of severe chronic venous disease by
saphenous ablation and venous outflow stenting in one
stage gives excellent symptom relief, well-maintained ulcer-
healing rate, and improves significantly the patient’s quality
of life. These results are even achieved in patients with deep
axial venous reflux, which was left untreated in the patients
in this study. The results appear to be durable, at least in the
mid-term, and certainly make it possible to postpone more
invasive surgery.
Deep reflux was observedmore frequently in limbs with
failure of ulcer healing in this study, and open deep valve
repair may be required later. When percutaneous repair of
the deep valves or replacement of deep valve stations has
been developed, it may be added to the treatment arsenal at
an earlier stage. The combination of percutaneous stenting
and GSV ablation makes this one-stage intervention truly
minimally invasive.
It may be argued that one should perform individual
interventions in stages. Our experience is that this prolongs
the duration of treatment and time to symptom relief. In a
multisystem, multilevel disease, the treatment should be
directed towards the pivotal diseased venous segment, if
such a segment does exist. Perhaps it is entirely presump-
tuous of us to expect complete symptom relief by treating a
single system/level. In any case, presently it is impossible to
identify this pivotal segment. In fact, we are presently
unable to quantify segmental reflux or obstruction or de-
scribe how they interact. The choice of type of individual
intervention would therefore be purely conjecture. The
basis for intervention would probably be simplicity of in-
tervention.
Partial treatmentmay also only achieve partial symptom
relief, which may be temporary. The introduction of the
CEAP classification has been a major step towards appro-
priate definition of venous disease and report standards.
Chronic venous disease is very complex and so is its symp-
tomatology. Substantial leg pain and gross swelling can be
present without skin changes,17 which is not necessarily
reflected in the severity classification. Swelling may existwithout pain and vice versa. The C in CEAP lacks power to
evaluate the detailed impact of swelling and pain on clinical
severity and needs to be complemented, perhaps, by mea-
surement of degree of swelling, a visual analogue pain scale,
and quality-of-life assessment. The use of these measure-
ments in the present study showed substantial and statisti-
cally significant improvement in all these aspects.
It is a mistake to assume that when a venous ulcer heals
the patient becomes asymptomatic. Leg pain may not be
attributed to the presence of ulcer alone.18 Different patho-
physiologic aspects of venous disease may result in varying
symptoms. Obstruction appears to project itself mainly as
pain, and ulcer formation is rare without reflux.17 A com-
bination of both may contribute to the development of
swelling. In our experience, gross swelling requires a com-
ponent of obstruction. The superficial and axial deep reflux
will not improve or deteriorate when only iliofemoral stent-
ing is performed in limbs with combined pathology.17
Multiple interventions would, therefore, have a greater
chance to achieve better and sustained symptom relief, as in
this study.
This study spans many years and the technique of
controlling the superficial reflux has evolved. GSV stripping
performed in presence of intraoperative anticoagulation
resulted in unreasonably high rate of complications (23%).
The introduction of endovenous ablation procedures sub-
stantially decreased the rate and severity of complications,
most of which are minor. For no obvious reason, the
saphenous veins remained occluded at a higher rate after
laser treatment.
The patients with failed ulcer healing had a higher rate
of axial deep reflux and failed to decrease the amount of
global reflux, since VFI90 remained unchanged. Axial deep
reflux is frequently observed with severe chronic venous
disease,19,20 and may be the sole cause of treatment failure
in this group of patients. The failure to maintain the GSV
closed by endovenous ablation may also contribute to the
lack of decrease of global reflux. Even if the GSV remains
open and refluxing, however, the global reflux and symp-
toms may be improved because of the removal of branch
varicosities and perforators. The reasons for treatment fail-
ure may be many. Owing to the size of the material in this
study, firm conclusions cannot be made in this regard.
CONCLUSION
The evolving basis for management of patients with
chronic venous disease is to accurately verify and classify the
presence of venous dysfunction. The initial treatment in
symptomatic patients must take into account the degree
and distribution of valve reflux and outflow obstruction. It
seems logical to initially perform minimally invasive percu-
taneous stenting and saphenous ablation rather than open
surgery in patients with venous outflow obstruction and
superficial reflux. These interventions do not exclude si-
multaneous nonoperative treatment such as compression
therapy, which if accepted by the patient, may be seen as
complimentary.
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